II. Indications: Inpatient and Emergency Department
III. Indications: Outpatient
- Sedation in surgical, Medical and Psychiatric procedures
- Seizure Disorder
- Alcohol Withdrawal and withdrawal from other drugs
-
Anxiety Disorder
- Consider limiting to short-term stabilization until SSRI or SNRI (e.g. Venlafaxine) takes effect
- Adjunct to Cognitive Behavioral Therapy and other Anxiety Management
-
Insomnia
- Consider alternative agents and methods (Trazodone, Melatonin, CBT-I, Sleep Hygiene)
- Consider Benzodiazepine Receptor Agonist instead (e.g. Ambien)
- Muscle spasm
IV. Contraindications
- Myasthenia Gravis
- Acute narrow-angle Glaucoma
- Substance Abuse (relative contraindication)
V. Mechanism
- Potentiates activity of Gamma-Aminobutyric Acid (GABA)
-
GABA is an inhibitory Neurotransmitter in the CNS
- Muscle relaxant
- Anticonvulsant
- Anxiolytic
- Anti-aggressiveness
- Sedation
VI. Precautions
- Benzodiazepines have significant risks
- Double the risk of Motor Vehicle Accidents, and falls (and Hip Fractures) in the elderly (see Beer's List)
- Double the risk of COPD exacerbations
- Associated with rising Overdose deaths in the United States (FDA black box warning in 2020)
- Benzodiazepine misuse and abuse is common
- Hospital admissions for Benzodiazepine Abuse have increased three-fold since the early 2000s
- Alprazolam is among the most addictive Benzodiazepines
- Responsible for 10% of drug-misuse related visits to the Emergency Department
- Rapid onset is associated with euphoria, short Half-Life is associated with rebound symptoms
- Avoid combining Benzodiazepines if possible
- Risk of falls, memory problems, excessive sedation
- Occasional, as needed dosing of a short acting Benzodiazepine may be approriate longterm in some patients
- However, longterm regular or scheduled use is generally not recommended
- Frequent prn dosing should prompt re-evaluation
- Consider tapering off Benzodiazepine or switching to long-acting Benzodiazepine dose
- Non-Benzodiazepine Sedatives (e.g. Ambien) can have additive effects with Benzodiazepines
- References
- (2014) Presc Lett 21(8): 45
- Zigman (2012) J Psychopharmacol 26: 1507-11 [PubMed]
VII. Advantages
- Rapid onset of action
- Anxiolytic effect within 1-2 days
- Tolerance develops rapidly to adverse effects
- Tolerance does not develop for Anxiolytic effect
- Few Drug Interactions
- Good safety profile
VIII. Medications: Benzodiazepines
- Long Acting Benzodiazepines
- Chlordiazepoxide (Librium)
- Diazepam (Valium, Valrelease)
- Flurazepam (Dalmane)
- Chlorazepate (Tranxene)
- Clonazepam (Klonopin)
- Quazepam (Doral)
- Halazepam (Paxipam)
- Medium Acting Benzodiazepines
- Short acting Benzodiazepines
IX. Medications: Other Sedative-Hypnotics
- Z-Drug (e.g. Zolpidem)
- Barbiturate (e.g. Barbiturates)
- Gamma Hydroxybutyrate (GHB)
- Gamma Butyrolactone
X. Absorption
XI. Metabolism
- Renal Excretion
- Hepatic Metabolism
- Microsomal oxidation
- Conjugation by glucuronyl transferases
- Metabolic pathways
- Clonazepam metabolizes to 7-aminoclonazepam
- Alprazolam metabolizes to Alpha-hydroxyalprazolam
- Chlordiazepoxide metabolizes to Oxazepam (via Norchlordiazepoxide, Demoxepam, Nordiazepam)
- Medazepam metabolizes to Oxazepam (via Nordiazepam) and Diazepam
- Diazepam metabolizes to Oxazepam (via Nordiazepam) and Temazepam
- Temazepam metabolizes to Oxazepam
- Agents that metabolize to Oxazepam via nordiazepam
- Diazepam
- Demoxepam
- Halazepam
- Chlorazepate
- Prezapam
- References
- Valentine (1996) J Anal Toxicol 20(6): 416-24 +PMID:8889678
XII. Dosing: Strategies
- Initiate treatment with low dose Benzodiazepine
- Prevent symptoms completely by using a regular regimen
- Escalate dose slowly, no more often than every 2 weeks
- Maintain lowest effective dose for several months
- Start with 50% of typical dose in at risk cohorts
- Elderly
- Hepatic dysfunction
- Renal dysfunction
- Tapering dose
- Periodically attempt to lower dose or ideally, titrate off completely
- Indications for prolonged taper periods (2-4 weeks per dose step-down)
- Higher Benzodiazepine doses
- Longer duration of Benzodiazepine use
- Short-acting Benzodiazepines (e.g. Alprazolam, Lorazepam)
- Example taper protocol
- Decrease dose by 25% for 1 week (2-4 weeks if prolonged taper indicated) THEN
- Decrease dose by 25% for 1 week (or 2-4 weeks if prolonged taper indicated) THEN
- Decrease dose by 10% per 1 week (or 2-4 weeks if prolonged taper indicated) until off
- Change to longer Half-Life drug if symptom breakthrough
- Example: Switch from Xanax to Clonazepam
XIII. Dosing: Equivalent to Valium 60 mg (for withdrawal)
- High Potency Benzodiazepines
- Alprazolam (Xanax) 6 mg
- Clonazepam (Klonopin) 24 mg
- Lorazepam (Ativan) 12 mg
- Low Potency Benzodiazepines
- Chlordiazepoxide (Limbitrol) 150 mg
- Flurazepam (Dalmane) 90 mg
- Halazepam (Paxipam) 240 mg
- Oxazepam (Serax) 60 mg
- Temazepam (Restoril) 60 mg
XIV. Safety: Pregnancy and Lactation
- Pregnancy Category: D
- Lactation: Not allowed
XV. Adverse Effects
-
Drug Dependence
- Risk Benzodiazepine Withdrawal (Seizures may occur, especially if underlying Seizure Disorder)
- Sedation
- Nausea
- Blood dyscrasia
- Anterograde Amnesia
- Cognitive Impairment
- Respiratory depression
- Hyponatremia or Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
XVI. Monitoring: Consider in patients on longterm therapy
XVII. References
- (2020) Presc Lett 27(12): 68-9
- Tasman (1997) Psychiatry, Saunders, p. 1641-6 [PubMed]
- Katzung (1989) Pharmacology, Lange, p. 264-7 [PubMed]